112 related articles for article (PubMed ID: 15955854)
21. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
[TBL] [Abstract][Full Text] [Related]
22. [Endovascular gamma-irradiation for prevention or restenosis after angioplasty of femoropopliteal de-novo-stenoses-long-term results of a feasibility study].
Krüger K; Bendel M; Zähringer M; Bongartz R; Nolte M; Schulte O; Lackner K
Rofo; 2002 Mar; 174(3):321-7. PubMed ID: 11885010
[TBL] [Abstract][Full Text] [Related]
23. Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventions.
Schillinger M; Mlekusch W; Wolfram RM; Budinsky AC; Exner M; Rumpold H; Wagner O; Pokrajac B; Pötter R; Minar E
Radiology; 2004 Feb; 230(2):556-60. PubMed ID: 14752194
[TBL] [Abstract][Full Text] [Related]
24. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time.
Diehm N; Silvestro A; Do DD; Greiner R; Triller J; Mahler F; Baumgartner I
J Endovasc Ther; 2005 Dec; 12(6):723-30. PubMed ID: 16363902
[TBL] [Abstract][Full Text] [Related]
25. Endovascular brachytherapy in the femoropopliteal segment using 192Ir and 188Re.
Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
Cardiovasc Intervent Radiol; 2008; 31(4):698-708. PubMed ID: 18185955
[TBL] [Abstract][Full Text] [Related]
26. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging.
Wyttenbach R; Gallino A; Alerci M; Mahler F; Cozzi L; Di Valentino M; Badimon JJ; Fuster V; Corti R
Circulation; 2004 Aug; 110(9):1156-61. PubMed ID: 15326071
[TBL] [Abstract][Full Text] [Related]
27. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
[TBL] [Abstract][Full Text] [Related]
28. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial.
Brodmann M; Rief P; Froehlich H; Dorr A; Gary T; Eller P; Hafner F; Deutschmann H; Seinost G; Pilger E
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):69-74. PubMed ID: 23007223
[TBL] [Abstract][Full Text] [Related]
29. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
Gallino A; Do DD; Alerci M; Baumgartner I; Cozzi L; Segatto JM; Bernier J; Tutta P; Kellner F; Triller J; Schneider E; Amann-Vesti B; Studer G; Jäger K; Aschwanden M; Canevascini R; Jacob AL; Kann R; Greiner R; Mahler F
J Endovasc Ther; 2004 Dec; 11(6):595-604. PubMed ID: 15615549
[TBL] [Abstract][Full Text] [Related]
30. Femoropopliteal artery: initial and 6-month results of color duplex US-guided percutaneous transluminal angioplasty.
Katzenschlager R; Ahmadi A; Minar E; Koppensteiner R; Maca T; Pikesch K; Stümpflen A; Ugurluoglu A; Ehringer H
Radiology; 1996 May; 199(2):331-4. PubMed ID: 8668773
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
Costanza MJ; Queral LA; Lilly MP; Finn WR
J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
[TBL] [Abstract][Full Text] [Related]
32. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions.
Zehnder T; von Briel C; Baumgartner I; Triller J; Greiner R; Mahler F; Do DD
J Endovasc Ther; 2003 Apr; 10(2):304-11. PubMed ID: 12877614
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
[TBL] [Abstract][Full Text] [Related]
34. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results.
Wolfram RM; Pokrajac B; Ahmadi R; Fellner C; Gyöngyösi M; Haumer M; Bucek R; Pötter R; Minar E
Radiology; 2001 Sep; 220(3):724-9. PubMed ID: 11526274
[TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
[TBL] [Abstract][Full Text] [Related]
36. Endovascular brachytherapy and restenosis following lower limb angioplasty: Systematic review and meta-analysis of randomized clinical trials.
Mitchell D; O'Callaghan AP; Boyle EM; Kavanagh EG; Walsh SR
Int J Surg; 2012; 10(3):124-8. PubMed ID: 22349154
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous angioplasty and stenting of the superficial femoral artery.
Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
[TBL] [Abstract][Full Text] [Related]
38. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts.
Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Schwarzinger I; Wagner O; Minar E
J Endovasc Ther; 2003 Jun; 10(3):557-65. PubMed ID: 12932168
[TBL] [Abstract][Full Text] [Related]
39. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
Kasapis C; Henke PK; Chetcuti SJ; Koenig GC; Rectenwald JE; Krishnamurthy VN; Grossman PM; Gurm HS
Eur Heart J; 2009 Jan; 30(1):44-55. PubMed ID: 19028778
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations.
Exner M; Schillinger M; Minar E; Mlekusch W; Sabeti S; Endler G; Raith M; Mannhalter C; Wagner O
Radiology; 2004 Jun; 231(3):839-44. PubMed ID: 15105457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
